Raised HDL cholesterol in Fabry disease: response to enzyme replacement therapy.
J Inherit Metab Dis
; 27(6): 791-3, 2004.
Article
en En
| MEDLINE
| ID: mdl-15617195
Fabry disease patients have increased risk of vascular disease despite cardioprotective increased HDL-cholesterol. Enzyme therapy does not significantly alter the lipid profile in the short term.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Fabry
/
Alfa-Galactosidasa
/
Hipercolesterolemia
/
HDL-Colesterol
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Inherit Metab Dis
Año:
2004
Tipo del documento:
Article
Pais de publicación:
Estados Unidos